4//SEC Filing
Fraser Claire 4
Accession 0000899243-23-001007
CIK 0001609809other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:35 PM ET
Size
5.5 KB
Accession
0000899243-23-001007
Insider Transaction Report
Form 4
Fraser-Liggett Claire
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-04+48,000→ 48,000 totalExercise: $5.47Exp: 2033-01-03→ Common Stock (48,000 underlying)
Footnotes (1)
- [F1]The option will vest in four equal installments on each anniversary of January 4, 2023 or in full immediately prior to the occurrence of a change in control.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001382031
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:35 PM ET
- Size
- 5.5 KB